Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Glioblastoma”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Study completedNCT01260506
What this trial is testing

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Vascular Biogenics Ltd. operating as VBL Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT00875433
What this trial is testing

Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 60
Not applicableUnknownNCT05539339
What this trial is testing

Personalized Trial in ctDNA-level-relapse Glioblastoma

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02942264
What this trial is testing

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
Brain TumorAstrocytomaAstroglioma+2 more
National Cancer Institute (NCI) 53
Early research (Phase 1)UnknownNCT01972750
What this trial is testing

Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma

Who this might be right for
First or Second Recurrence of Glioblastoma
PD Dr. Martin Glas 12
Testing effectiveness (Phase 2)Looking for participantsNCT01269853
What this trial is testing

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 54
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT06356883
What this trial is testing

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

Who this might be right for
Glioblastoma MultiformeRelapse
Université de Sherbrooke 120
Early research (Phase 1)Study completedNCT00968240
What this trial is testing

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 30
Early research (Phase 1)Ended earlyNCT04047303
What this trial is testing

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
AstrocytomaGlioblastoma
Celgene 20
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Early research (Phase 1)Study completedNCT01238237
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

Who this might be right for
Glioblastoma Multiforme (GBM)ANAPLASTIC ASTROCYTOMA (AOA)GBM+1 more
Northwell Health 15
Testing effectiveness (Phase 2)Looking for participantsNCT03672721
What this trial is testing

IA Carboplatin + Radiotherapy in Relapsing GBM

Who this might be right for
Glioblastoma MultiformeRelapse
Université de Sherbrooke 35
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Testing effectiveness (Phase 2)Study completedNCT02926222
What this trial is testing

Regorafenib in Relapsed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Istituto Oncologico Veneto IRCCS 119
Early research (Phase 1)WithdrawnNCT04270461
What this trial is testing

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Who this might be right for
Hepatocellular CarcinomaGlioblastomaMedulloblastoma+1 more
Jiujiang University Affiliated Hospital
Testing effectiveness (Phase 2)Ended earlyNCT01884740
What this trial is testing

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

Who this might be right for
Glioblastoma MultiformeFibrillary Astrocytoma of BrainGlioma of Brainstem+5 more
Weill Medical College of Cornell University 13
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00016991
What this trial is testing

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Load More Results